Ganciclovir

Ganciclovir Reactions 1680, p149 - 2 Dec 2017 Right bundle branch block: case report A 12-year-old boy developed right bundle branch block (RBBB) during treatment with ganciclovir [Cymevene; dosage and duration of treatment to reaction onset not stated]. The boy was hospitalised due to chest pain and shortness of breath. He initially developed runny nose, fever and cough, which later progressed to chest pain and shortness of breath over 10 days. Upon hospitalisation, he developed tachypnoea, tachycardia and fever. Subsequently, he was started on empirical treatment with various IV unspecified antibiotics. However, his condition continued to deteriorate, and required ventilatory support. Thereafter, his antibiotic therapy was upgraded, but he developed severe acute respiratory distress syndrome and septic shock. After that, unspecified antifungals were also added to his treatment regimen, and inotropic support was provided. Despite receiving aggressive treatment, his condition continued to worsen and he developed hypotension, acute kidney injury and multi organ failure. Later, lung biopsy was performed, which led to the diagnosis of CMV pneumonitis. Hence, his treatment was initiated with IV ganciclovir. The treatment resulted in a significant improvement, and his fever subsided. The inotropic support and ventilation were withdrawn. However, during the treatment he developed RBBB. The boy’s ganciclovir dose was reduced, and RBBB resolved. He recovered completely, and was discharged after 21 days of hospitalisation. Author comment: "During Ganciclovir treatment course, the patient developed right bundle branch block (RBBB) probably as a rare side effect of Ganciclovir therapy. . .Rather than using a sole clinical judgment, score of 5 on Naranjo causality scale,indicates a probable relationship between Ganciclovir administration and RBBB." Al-Eyadhy AA, et al. Cytomegalovirus associated severe pneumonia, multi-organ failure and Ganciclovir associated arrhythmia in immunocompetent child. Journal of Infection and Chemotherapy 23: 844-847, No. 12, Dec 2017. Available from: URL: http://doi.org/10.1016/j.jiac.2017.08.003 - Saudi Arabia 803284473 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Ganciclovir

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/ganciclovir-ZQfCaamshs
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39080-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial